COCP
Price
$1.49
Change
-$0.03 (-1.97%)
Updated
Jun 27 closing price
Capitalization
15.87M
INM
Price
$3.38
Change
-$0.08 (-2.31%)
Updated
Jun 27 closing price
Capitalization
4.08M
Interact to see
Advertisement

COCP vs INM

Header iconCOCP vs INM Comparison
Open Charts COCP vs INMBanner chart's image
Cocrystal Pharma
Price$1.49
Change-$0.03 (-1.97%)
Volume$26.79K
Capitalization15.87M
InMed Pharmaceuticals
Price$3.38
Change-$0.08 (-2.31%)
Volume$257.8K
Capitalization4.08M
COCP vs INM Comparison Chart in %
Loading...
COCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COCP vs. INM commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COCP is a Buy and INM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (COCP: $1.49 vs. INM: $3.38)
Brand notoriety: COCP and INM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COCP: 128% vs. INM: 6%
Market capitalization -- COCP: $15.16M vs. INM: $4.08M
COCP [@Biotechnology] is valued at $15.16M. INM’s [@Biotechnology] market capitalization is $4.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COCP’s FA Score shows that 0 FA rating(s) are green whileINM’s FA Score has 0 green FA rating(s).

  • COCP’s FA Score: 0 green, 5 red.
  • INM’s FA Score: 0 green, 5 red.
According to our system of comparison, INM is a better buy in the long-term than COCP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COCP’s TA Score shows that 3 TA indicator(s) are bullish while INM’s TA Score has 6 bullish TA indicator(s).

  • COCP’s TA Score: 3 bullish, 5 bearish.
  • INM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, INM is a better buy in the short-term than COCP.

Price Growth

COCP (@Biotechnology) experienced а 0.00% price change this week, while INM (@Biotechnology) price change was +35.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COCP($15.9M) has a higher market cap than INM($4.08M). COCP (-26.238) and INM (-26.362) have similar YTD gains . INM has higher annual earnings (EBITDA): -7.86M vs. COCP (-15.63M). COCP has more cash in the bank: 6.92M vs. INM (4.68M). INM has less debt than COCP: INM (849K) vs COCP (1.73M). INM has higher revenues than COCP: INM (4.92M) vs COCP (0).
COCPINMCOCP / INM
Capitalization15.9M4.08M390%
EBITDA-15.63M-7.86M199%
Gain YTD-26.238-26.362100%
P/E RatioN/A0.01-
Revenue04.92M-
Total Cash6.92M4.68M148%
Total Debt1.73M849K204%
FUNDAMENTALS RATINGS
COCP vs INM: Fundamental Ratings
COCP
INM
OUTLOOK RATING
1..100
6599
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6441
P/E GROWTH RATING
1..100
9982
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INM's Valuation (40) in the null industry is in the same range as COCP (69) in the Pharmaceuticals Generic industry. This means that INM’s stock grew similarly to COCP’s over the last 12 months.

INM's Profit vs Risk Rating (100) in the null industry is in the same range as COCP (100) in the Pharmaceuticals Generic industry. This means that INM’s stock grew similarly to COCP’s over the last 12 months.

INM's SMR Rating (98) in the null industry is in the same range as COCP (98) in the Pharmaceuticals Generic industry. This means that INM’s stock grew similarly to COCP’s over the last 12 months.

INM's Price Growth Rating (41) in the null industry is in the same range as COCP (64) in the Pharmaceuticals Generic industry. This means that INM’s stock grew similarly to COCP’s over the last 12 months.

INM's P/E Growth Rating (82) in the null industry is in the same range as COCP (99) in the Pharmaceuticals Generic industry. This means that INM’s stock grew similarly to COCP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COCPINM
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNTX106.720.58
+0.55%
BioNTech SE American Depositary Share
SMPL31.910.16
+0.50%
Simply Good Foods Company (The)
VTOL33.350.04
+0.12%
Bristow Group
HOOK1.25N/A
N/A
HOOKIPA Pharma Inc.
BZUN2.51-0.07
-2.52%
Baozun

COCP and

Correlation & Price change

A.I.dvisor tells us that COCP and SGMO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COCP and SGMO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COCP
1D Price
Change %
COCP100%
-1.97%
SGMO - COCP
26%
Poorly correlated
N/A
NLSP - COCP
26%
Poorly correlated
+9.84%
INM - COCP
25%
Poorly correlated
-2.31%
TRAW - COCP
23%
Poorly correlated
N/A
GSGTF - COCP
23%
Poorly correlated
N/A
More

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with OMER. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then OMER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
-2.31%
OMER - INM
46%
Loosely correlated
-3.61%
TTNP - INM
43%
Loosely correlated
-1.79%
SPHDF - INM
33%
Poorly correlated
N/A
XFOR - INM
32%
Poorly correlated
-8.50%
SQZB - INM
29%
Poorly correlated
N/A
More